MANUEL
PRAGA TERENTE
Profesor emérito
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (26)
2024
-
Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia
Kidney International Reports
-
Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis
Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 328-340
2023
-
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
Kidney360, Vol. 4, Núm. 5, pp. 659-672
-
Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis
Nefrologia, Vol. 43, Núm. 1, pp. 6-47
2022
-
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746
-
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280
2021
-
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Kidney International, Vol. 99, Núm. 4, pp. 986-998
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2020
-
Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease
Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298
2019
-
IgA nephropathy in elderly patients
Clinical Journal of the American Society of Nephrology, Vol. 14, Núm. 8, pp. 1183-1192
2017
-
Elevated factor H–related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy
Kidney International, Vol. 92, Núm. 4, pp. 953-963
2016
-
Altered underlying renal tubular function in patients with chronic hepatitis B receiving nucleos(t)ide analogs in a real-world setting the MENTE study
Journal of Clinical Gastroenterology, Vol. 50, Núm. 9, pp. 779-789
-
Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis
Clinical Kidney Journal, Vol. 9, Núm. 3, pp. 381-386
2015
-
An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document
Nefrologia
-
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
Kidney International, Vol. 88, Núm. 5, pp. 1153-1160
2014
-
Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 9, pp. 583-597
-
Resumen ejecutivo del documento de consenso sobre el manejo de la patología renal en pacientes con infección por VIH
Nefrologia, Vol. 34, Núm. 6, pp. 768-788
2012
-
Diagnosis and treatment of Lupus nephritis: Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish society of internal medicine (SEMI) and the Spanish society of nephrology (S.E.N.)
Nefrologia, Vol. 32, Núm. SUPPL. 1, pp. 1-45
-
Diagnosis and treatment of lupus nephritis
Revista Clinica Espanola
-
Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria
Journal of the American Society of Nephrology, Vol. 23, Núm. 10, pp. 1753-1760